Literature DB >> 286609

Self-renewal in culture of proliferative blast progenitor cells in acute myeloblastic leukemia.

R N Buick, M D Minden, E A McCulloch.   

Abstract

We have proposed that colonies of cells with blastlike morphology growing in culture are derived from a blast subpopulation with high proliferative potential. To test whether or not these blast progenitors have the capacity for self-renewal, blast colonies grown from the peripheral blood of the 21 patients with acute myeloblastic leukemia were replated; secondary colonies were observed in 17 instances, and these were similar to primary colonies in size, morphology, and culture requirements. Great patient-to-patient variation was observed in the frequency of secondary colonies, but low secondary plating efficiency was significantly correlated with successful remission induction. We conclude that the blast progenitors detected in the assay have at least limited self-renewal capacity and that this capacity may, along with other risk factors, contribute to clinical outcome.

Entities:  

Mesh:

Year:  1979        PMID: 286609

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  PLAGL2 regulates Wnt signaling to impede differentiation in neural stem cells and gliomas.

Authors:  Hongwu Zheng; Haoqiang Ying; Ruprecht Wiedemeyer; Haiyan Yan; Steven N Quayle; Elena V Ivanova; Ji-Hye Paik; Hailei Zhang; Yonghong Xiao; Samuel R Perry; Jian Hu; Anant Vinjamoori; Boyi Gan; Ergun Sahin; Milan G Chheda; Cameron Brennan; Y Alan Wang; William C Hahn; Lynda Chin; Ronald A DePinho
Journal:  Cancer Cell       Date:  2010-05-18       Impact factor: 31.743

2.  Disconnection of genes coding for self-renewal and differentiation: a possible mechanism of diversity in acute myeloid leukemias.

Authors:  H von Melchner; K Höffken
Journal:  Blut       Date:  1985-05

3.  Growth factors from tumor microenvironment possibly promote the proliferation of glioblastoma-derived stem-like cells in vitro.

Authors:  JingJing Guo; Rui Niu; Wenhui Huang; Mengliang Zhou; Jixing Shi; Luyong Zhang; Hong Liao
Journal:  Pathol Oncol Res       Date:  2012-07-28       Impact factor: 3.201

4.  A Prominin-1-Rich Pediatric Glioblastoma: Biologic Behavior Is Determined by Oxygen Tension-Modulated CD133 Expression but Not Accompanied by Underlying Molecular Profiles.

Authors:  Laura K Donovan; Nicola E Potter; Tracy Warr; Geoffrey J Pilkington
Journal:  Transl Oncol       Date:  2012-06-01       Impact factor: 4.243

5.  Clonogenicity of normal and malignant hematopoietic progenitor cells after exposure to synthetic alkyl-lymphospholipids.

Authors:  I Dulisch; H A Neumann; G W Löhr; R Andreesen
Journal:  Blut       Date:  1985-12

6.  Proliferation and cell loss of human leukemic cell subpopulations in liquid culture.

Authors:  P A Bernabei; F C Agostino; R Bezzini; R Saccardi; V Gattei; V Santini; M Casini; P Rossi Ferrini
Journal:  Experientia       Date:  1988-03-15

7.  Immunoperoxidase staining of early human melanoma colonies with monoclonal antibodies. A new method for in vitro antigenic-morphologic correlation.

Authors:  G M Nakano; R B Natale; A F Lobuglio; A N Houghton
Journal:  Am J Pathol       Date:  1984-03       Impact factor: 4.307

8.  Inhibition of the self-renewal capacity of blast progenitors from acute myeloblastic leukemia patients by site-selective 8-chloroadenosine 3',5'-cyclic monophosphate.

Authors:  A Pinto; D Aldinucci; V Gattei; V Zagonel; G Tortora; A Budillon; Y S Cho-Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-01       Impact factor: 11.205

9.  Heterogeneity of clonogenic cells in acute myeloblastic leukemia.

Authors:  K D Sabbath; E D Ball; P Larcom; R B Davis; J D Griffin
Journal:  J Clin Invest       Date:  1985-02       Impact factor: 14.808

10.  Replating efficiency of metastatic melanoma cells from lymph node and subcutaneous sites does not predict patient survival.

Authors:  F L Meyskens; S P Thomson; J Buckmeier
Journal:  Clin Exp Metastasis       Date:  1989 Nov-Dec       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.